USPTO Seeks Comments on Patent Law Harmonization -
USPTO SealLast week, the U.S. Patent and Trademark Office issued a notice in the Federal Register (78 Fed. Reg. 7411) seeking comments on matters related to the...more
Last Friday, the U.S. Patent and Trademark Office published a final rule in the Federal Register (78 Fed. Reg. 4212) setting and adjusting certain patent fees pursuant to the Office's fee-setting authority under § 10 of the...more
The U.S. Patent and Trademark Office published a notice in the Federal Register (78 Fed. Reg. 2960) earlier today requesting public comment regarding potential practices that applicants can employ in the drafting of patent...more
In a Federal Register notice published earlier today (78 Fed. Reg. 2256), the U.S. Patent and Trademark Office announced that the Extended Missing Parts Pilot Program that was implemented two years ago would be extended for...more
USPTO and EPO Announce Formal Launch of Cooperative Patent Classification System -
On January 2, both the U.S. Patent and Trademark Office and European Patent Office announced the formal launch of the Cooperative Patent...more
Reflecting upon the events of the past twelve months, Patent Docs presents its sixth annual list of top biotech/pharma patent stories. For 2012, we identified fifteen stories that were covered on Patent Docs last year that...more
1/2/2013
/ Diagnostic Method ,
EU ,
Federal Trade Commission (FTC) ,
Infringement ,
Patent Term Adjustment ,
Patents ,
Pharmaceutical Industry ,
Reverse Payment Settlement Agreements ,
Unified Patent Court ,
Unitary Patent ,
USPTO
Last week, the U.S. Patent and Trademark Office published a notice in the Federal Register (77 Fed. Reg. 75019) issuing the Office's final rule implementing the micro entity provision of § 10 of the Leahy-Smith America...more
Last week, the U.S. Patent and Trademark Office published a notice in the Federal Register (77 Fed. Reg. 72830) seeking public feedback on Request for Continued Examination (RCE) practice. The notice indicates that the...more
In a notice published last week in the Federal Register (77 Fed. Reg. 71170), the U.S. Patent and Trademark Office announced that it was interested in gathering "additional information" on independent second opinion genetic...more
In an opinion issued earlier this month, Judge Ellen Segal Huvelle of the U.S. District Court for the District of Columbia determined that Novartis AG and Novartis Vaccines and Diagnostics, Inc. had not satisfied the 180-day...more